L-MGH
Product Description
Anhui Biochem Pharmaceutical Co.,Ltd
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
Anhui Biochem Pharmaceutical Co.,Ltd
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
More Products from Anhui Biochem Pharmaceutical Co.,Ltd (56)
-
Product Entecavir
• Anti HBV • Entecavir Monohydrate -
Product Entecavir Dispersible Tablets
It is used for the treatment of HBV. -
Product Ethambutol Hydrochloride
Anti-infection -
Product FCME
An intermediate of Emtricitabine -
Product HME
An intermediate of Lamivudine -
Product Iguratimod
It is used for the treatment of rheumatic diseases. -
Product Lafutidine
It is used for the treatment of gastrointestinal diseases. -
Product Lamivudine
• Anti HIV/HBV -
Product Lamivudine Salicylate
An intermediate of Lamivudine -
Product Lamivudine Tablets
It is used for the treatment of HBV. -
Product Lamivudine+Tenofovir Disoproxil Fumarate Tablets
It is used for the treatment of HIV. -
Product Levodopa+Benserazide Hydrochloride Tablets
It is used for the treatment of Parkinson's disease.
Anhui Biochem Pharmaceutical Co.,Ltd resources (1)
-
Video Company Introduction
In 2007, Anhui Biochem United Pharmaceutical Co., Ltd. was set up in Tai he County.
In 2008, Anhui Biochem Bio-pharmaceutical Co., Ltd. sets foot in Hefei.
In 2009, Anhui Biochem Medical Sales Company Ltd. is established.
Anhui Biochem has expanded from processing generic drug materials to a fully integrated enterprise,covering API research,synthesis,and formulation production and sales.
In 2021, Anhui Biochem steps into the new stage.
Anhui Biochem sticks to core mission of "Keep HIV/AIDS and HBV from Mankind" all the way.